img

Global Knee Osteoarthritis Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Knee Osteoarthritis Treatment Market Research Report 2024

Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.
According to Mr Accuracy reports’s new survey, global Knee Osteoarthritis Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Knee Osteoarthritis Treatment market research.
Key companies engaged in the Knee Osteoarthritis Treatment industry include Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson and GlaxoSmithKline, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Knee Osteoarthritis Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Knee Osteoarthritis Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Knee Osteoarthritis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bioventus
AVM Biotechnology
Anika Therapeutics
Flexion Therapeutics
OrthoTrophix
Sanofi
Horizon Therapeutics
Johnson and Johnson
GlaxoSmithKline
Bayer
Abbott
Pfizer
Eli Lilly
Segment by Type
Non-surgical Treatment
Surgical Treatment

Segment by Application


Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Knee Osteoarthritis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Non-surgical Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Knee Osteoarthritis Treatment Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Knee Osteoarthritis Treatment Market Perspective (2018-2034)
2.2 Knee Osteoarthritis Treatment Growth Trends by Region
2.2.1 Global Knee Osteoarthritis Treatment Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Knee Osteoarthritis Treatment Historic Market Size by Region (2018-2024)
2.2.3 Knee Osteoarthritis Treatment Forecasted Market Size by Region (2024-2034)
2.3 Knee Osteoarthritis Treatment Market Dynamics
2.3.1 Knee Osteoarthritis Treatment Industry Trends
2.3.2 Knee Osteoarthritis Treatment Market Drivers
2.3.3 Knee Osteoarthritis Treatment Market Challenges
2.3.4 Knee Osteoarthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Knee Osteoarthritis Treatment Players by Revenue
3.1.1 Global Top Knee Osteoarthritis Treatment Players by Revenue (2018-2024)
3.1.2 Global Knee Osteoarthritis Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Knee Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Knee Osteoarthritis Treatment Revenue
3.4 Global Knee Osteoarthritis Treatment Market Concentration Ratio
3.4.1 Global Knee Osteoarthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Knee Osteoarthritis Treatment Revenue in 2022
3.5 Knee Osteoarthritis Treatment Key Players Head office and Area Served
3.6 Key Players Knee Osteoarthritis Treatment Product Solution and Service
3.7 Date of Enter into Knee Osteoarthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Knee Osteoarthritis Treatment Breakdown Data by Type
4.1 Global Knee Osteoarthritis Treatment Historic Market Size by Type (2018-2024)
4.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2024-2034)
5 Knee Osteoarthritis Treatment Breakdown Data by Application
5.1 Global Knee Osteoarthritis Treatment Historic Market Size by Application (2018-2024)
5.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Knee Osteoarthritis Treatment Market Size (2018-2034)
6.2 North America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Knee Osteoarthritis Treatment Market Size by Country (2018-2024)
6.4 North America Knee Osteoarthritis Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Knee Osteoarthritis Treatment Market Size (2018-2034)
7.2 Europe Knee Osteoarthritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Knee Osteoarthritis Treatment Market Size by Country (2018-2024)
7.4 Europe Knee Osteoarthritis Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Knee Osteoarthritis Treatment Market Size (2018-2034)
8.2 Asia-Pacific Knee Osteoarthritis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Knee Osteoarthritis Treatment Market Size (2018-2034)
9.2 Latin America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Knee Osteoarthritis Treatment Market Size by Country (2018-2024)
9.4 Latin America Knee Osteoarthritis Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Knee Osteoarthritis Treatment Market Size (2018-2034)
10.2 Middle East & Africa Knee Osteoarthritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bioventus
11.1.1 Bioventus Company Detail
11.1.2 Bioventus Business Overview
11.1.3 Bioventus Knee Osteoarthritis Treatment Introduction
11.1.4 Bioventus Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.1.5 Bioventus Recent Development
11.2 AVM Biotechnology
11.2.1 AVM Biotechnology Company Detail
11.2.2 AVM Biotechnology Business Overview
11.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Introduction
11.2.4 AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.2.5 AVM Biotechnology Recent Development
11.3 Anika Therapeutics
11.3.1 Anika Therapeutics Company Detail
11.3.2 Anika Therapeutics Business Overview
11.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Introduction
11.3.4 Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.3.5 Anika Therapeutics Recent Development
11.4 Flexion Therapeutics
11.4.1 Flexion Therapeutics Company Detail
11.4.2 Flexion Therapeutics Business Overview
11.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Introduction
11.4.4 Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.4.5 Flexion Therapeutics Recent Development
11.5 OrthoTrophix
11.5.1 OrthoTrophix Company Detail
11.5.2 OrthoTrophix Business Overview
11.5.3 OrthoTrophix Knee Osteoarthritis Treatment Introduction
11.5.4 OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.5.5 OrthoTrophix Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Knee Osteoarthritis Treatment Introduction
11.6.4 Sanofi Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.6.5 Sanofi Recent Development
11.7 Horizon Therapeutics
11.7.1 Horizon Therapeutics Company Detail
11.7.2 Horizon Therapeutics Business Overview
11.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Introduction
11.7.4 Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.7.5 Horizon Therapeutics Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Detail
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Introduction
11.8.4 Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.8.5 Johnson and Johnson Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Detail
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Introduction
11.9.4 GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.9.5 GlaxoSmithKline Recent Development
11.10 Bayer
11.10.1 Bayer Company Detail
11.10.2 Bayer Business Overview
11.10.3 Bayer Knee Osteoarthritis Treatment Introduction
11.10.4 Bayer Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.10.5 Bayer Recent Development
11.11 Abbott
11.11.1 Abbott Company Detail
11.11.2 Abbott Business Overview
11.11.3 Abbott Knee Osteoarthritis Treatment Introduction
11.11.4 Abbott Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.11.5 Abbott Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Knee Osteoarthritis Treatment Introduction
11.12.4 Pfizer Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.12.5 Pfizer Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Knee Osteoarthritis Treatment Introduction
11.13.4 Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2018-2024)
11.13.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of Non-surgical Treatment
Table 3. Key Players of Surgical Treatment
Table 4. Global Knee Osteoarthritis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 5. Global Knee Osteoarthritis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global Knee Osteoarthritis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Knee Osteoarthritis Treatment Market Share by Region (2018-2024)
Table 8. Global Knee Osteoarthritis Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Knee Osteoarthritis Treatment Market Share by Region (2024-2034)
Table 10. Knee Osteoarthritis Treatment Market Trends
Table 11. Knee Osteoarthritis Treatment Market Drivers
Table 12. Knee Osteoarthritis Treatment Market Challenges
Table 13. Knee Osteoarthritis Treatment Market Restraints
Table 14. Global Knee Osteoarthritis Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Knee Osteoarthritis Treatment Market Share by Players (2018-2024)
Table 16. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2022)
Table 17. Ranking of Global Top Knee Osteoarthritis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Knee Osteoarthritis Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Knee Osteoarthritis Treatment Product Solution and Service
Table 21. Date of Enter into Knee Osteoarthritis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Knee Osteoarthritis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2018-2024)
Table 25. Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2024-2034)
Table 27. Global Knee Osteoarthritis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2018-2024)
Table 29. Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2024-2034)
Table 31. North America Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 32. North America Knee Osteoarthritis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Knee Osteoarthritis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 35. Europe Knee Osteoarthritis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Knee Osteoarthritis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Knee Osteoarthritis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 41. Latin America Knee Osteoarthritis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Knee Osteoarthritis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 46. Bioventus Company Detail
Table 47. Bioventus Business Overview
Table 48. Bioventus Knee Osteoarthritis Treatment Product
Table 49. Bioventus Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 50. Bioventus Recent Development
Table 51. AVM Biotechnology Company Detail
Table 52. AVM Biotechnology Business Overview
Table 53. AVM Biotechnology Knee Osteoarthritis Treatment Product
Table 54. AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 55. AVM Biotechnology Recent Development
Table 56. Anika Therapeutics Company Detail
Table 57. Anika Therapeutics Business Overview
Table 58. Anika Therapeutics Knee Osteoarthritis Treatment Product
Table 59. Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 60. Anika Therapeutics Recent Development
Table 61. Flexion Therapeutics Company Detail
Table 62. Flexion Therapeutics Business Overview
Table 63. Flexion Therapeutics Knee Osteoarthritis Treatment Product
Table 64. Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 65. Flexion Therapeutics Recent Development
Table 66. OrthoTrophix Company Detail
Table 67. OrthoTrophix Business Overview
Table 68. OrthoTrophix Knee Osteoarthritis Treatment Product
Table 69. OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 70. OrthoTrophix Recent Development
Table 71. Sanofi Company Detail
Table 72. Sanofi Business Overview
Table 73. Sanofi Knee Osteoarthritis Treatment Product
Table 74. Sanofi Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Horizon Therapeutics Company Detail
Table 77. Horizon Therapeutics Business Overview
Table 78. Horizon Therapeutics Knee Osteoarthritis Treatment Product
Table 79. Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 80. Horizon Therapeutics Recent Development
Table 81. Johnson and Johnson Company Detail
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Knee Osteoarthritis Treatment Product
Table 84. Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 85. Johnson and Johnson Recent Development
Table 86. GlaxoSmithKline Company Detail
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Knee Osteoarthritis Treatment Product
Table 89. GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Bayer Company Detail
Table 92. Bayer Business Overview
Table 93. Bayer Knee Osteoarthritis Treatment Product
Table 94. Bayer Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. Abbott Company Detail
Table 97. Abbott Business Overview
Table 98. Abbott Knee Osteoarthritis Treatment Product
Table 99. Abbott Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 100. Abbott Recent Development
Table 101. Pfizer Company Detail
Table 102. Pfizer Business Overview
Table 103. Pfizer Knee Osteoarthritis Treatment Product
Table 104. Pfizer Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Eli Lilly Company Detail
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Knee Osteoarthritis Treatment Product
Table 109. Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2018-2024) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Knee Osteoarthritis Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Knee Osteoarthritis Treatment Market Share by Type: 2022 VS 2034
Figure 3. Non-surgical Treatment Features
Figure 4. Surgical Treatment Features
Figure 5. Global Knee Osteoarthritis Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Knee Osteoarthritis Treatment Market Share by Application: 2022 VS 2034
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Knee Osteoarthritis Treatment Report Years Considered
Figure 12. Global Knee Osteoarthritis Treatment Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Knee Osteoarthritis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Knee Osteoarthritis Treatment Market Share by Region: 2022 VS 2034
Figure 15. Global Knee Osteoarthritis Treatment Market Share by Players in 2022
Figure 16. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Knee Osteoarthritis Treatment Revenue in 2022
Figure 18. North America Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Knee Osteoarthritis Treatment Market Share by Country (2018-2034)
Figure 20. United States Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Knee Osteoarthritis Treatment Market Share by Country (2018-2034)
Figure 24. Germany Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Knee Osteoarthritis Treatment Market Share by Region (2018-2034)
Figure 32. China Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Knee Osteoarthritis Treatment Market Share by Country (2018-2034)
Figure 40. Mexico Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Knee Osteoarthritis Treatment Market Share by Country (2018-2034)
Figure 44. Turkey Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Knee Osteoarthritis Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Bioventus Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 47. AVM Biotechnology Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 48. Anika Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 49. Flexion Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 50. OrthoTrophix Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 51. Sanofi Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 52. Horizon Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 53. Johnson and Johnson Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 55. Bayer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 56. Abbott Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 57. Pfizer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 58. Eli Lilly Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed